What is Enformia?
Enformia Inc. is a technology firm specializing in cognitive assessment solutions. Their flagship product, Cogsuite, leverages principles from cognitive psychology and neuroscience to identify subtle cognitive impairments. Designed for remote administration, the platform is supported by neuropsychologists and has received backing from the National Cancer Institute. Enformia also offers a comprehensive suite of over 500 self-report instruments through its Self Report system, serving both general populations and individuals managing chronic conditions. The company's offerings are tailored for researchers and clinicians requiring robust data management and assessment capabilities.
How much funding has Enformia raised?
Enformia has raised a total of $48K across 1 funding round:
Debt
$48K
Debt (2021): $48K with participation from PPP
What's next for Enformia?
With substantial expansion capital secured, Enformia is poised for significant growth and strategic development. The company's focus on advanced cognitive assessment technology, supported by scientific validation and institutional backing, suggests a trajectory towards broader clinical adoption and potential market leadership. Future initiatives are likely to involve scaling operations, enhancing platform features, and expanding research collaborations to further solidify its position in the health tech landscape. This latest investment will fuel Enformia's mission to provide accessible and reliable cognitive health insights.
See full Enformia company page
